Ebola and Lassa fever targeted by new vaccine trial and improved surveillance

October 2018

Scientists hope that a new approach to vaccine development, combined with improved surveillance of potential future threats of outbreak, could help to massively reduce the impact of deadly diseases such as Ebola, Marburg and Lassa fever. "This has the potential to have an enormous positive impact on global public health"
Professor Jonathan Heeney, Vice-Master, Darwin College


Close menu
Site navigation mobile menu